Healthcare entity
Every one of those 1 sits in a single category, funding. Rakovina Therapeutics appears in 1 tracked Healthcare story from February 21, 2026. The tracked stories average 2 original sources each.
Last mentioned: Feb 21, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, funding. Rakovina Therapeutics appears in 1 tracked Healthcare story from February 21, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Rakovina Therapeutics has announced an upsized financing package totaling $2.0 million through a combination of convertible debentures and a private placement. The capital infusion is earmarked for near-term operations as the company advances its DNA damage response (DDR) cancer therapies.
Source: CBJ (ca) · manilatimes.net
Rakovina Therapeutics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
